Somatostatin analogues in the treatment of paraneoplastic hypercorticism
Lorcy, Y.; Le Moullec, N.; Le Guerrier, A.M.; Allannic, H.
Presse Medicale 21(39): 1873
1992
ISSN/ISBN: 0755-4982 PMID: 1494565 Document Number: 392017
Document emailed within 1 workday
Related Documents
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741Luton, J.P.; Chaumerliac, P.; Turpin, G.; Valcke, J.C.; Leprat, J.; Bricaire, H. 1972: Paraneoplastic hypercorticism. Apropos of 5 cases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 48(2): 111-120
Laron, Z. 1990: Somatostatin analogues in the management of benign insulinomas Israel Journal of Medical Sciences 26(1): 1-2
Anthony, L.B. 1999: Long-acting formulations of somatostatin analogues Italian Journal of Gastroenterology and Hepatology 31(Suppl): S216-S218
De Jong, M.; Breeman, W.A.; Bernard, H.F.; Kooij, P.P.; Slooter, G.D.; Van Eijck, C.H.; Kwekkeboom, D.J.; Valkema, R.; Mäcke, H.R.; Krenning, E.P. 1999: Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 43(4): 356-366
Breeman, W.A.; Bakker, W.H.; De Jong, M.; Hofland, L.J.; Kwekkeboom, D.J.; Kooij, P.P.; Visser, T.J.; Krenning, E.P. 1996: Studies on radiolabeled somatostatin analogues in rats and in patients Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 40(3): 209-220
García Lafuente, N.; Berná Gascón, M.T.; Pujalte López, E.; Falcó Jover, G.; Domínguez Escribano, J.R. 2001: Response of thyrotropinoma to somatostatin analogues: report of a case Anales de Medicina Interna 18(12): 663
Batzri, S.; Harmon, J.W. 1988: Effects of somatostatin and its analogues on dispersed gastric mucosal cells Surgery 104(5): 934
Vialettes, B.; Mallet, B. 1992: Somatostatin analogues: a therapeutic tool in proliferative diabetic retinopathy? Journees Annuelles de Diabetologie de l'Hotel-Dieu 1992: 63-70
Bodei, L.; Pepe, G.; Paganelli, G. 2010: Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues European Review for Medical and Pharmacological Sciences 14(4): 347-351
Setyono-Han, B.; Henkelman, M.S.; Foekens, J.A.; Klijn, G.M. 1987: Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells Cancer Research 47(6): 1566-1570
Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50
Gut, P.ł; Ruchała, M. 2019: Evaluation of 5-hydroxyindoloacetic acid excretion in urine in patients with small intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues Neuro Endocrinology Letters 40(7-8): 315-318
Kasperlik-Załuska, A.; Stopińska-Głuszak, U.; Hartwig, W.; Marianowski, L.; Niewiadomska, A. 1979: Pituitary-gonadal system in women with hypercorticism. Results of surgical and pharmacological treatment Ginekologia Polska 50(12): 1023-1028
Hofland, L.J. 2003: Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog Journal of Endocrinological Investigation 26(8 Suppl): 8-13
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C. 1993: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28 Molecular Pharmacology 44(6): 1278
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K. 1991: Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation Transplantation Proceedings 23(1 Part 1): 348
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229
Estève, J.P.; Susini, C.; Vaysse, N.; Gineston, J.L.; Pradayrol, L.; Wunsch, E.; Ribet, A. 1982: Effect of somatostatin 14, as natural and synthetic somatostatin 28 on pentagastrin-stimulated gastric acid and pancreatic secretions in conscious dogs Gastroenterologie Clinique et Biologique 6(6-7): 576-580